[๐ขEfficacy of the STC-1010, a new allogeneic cancer vaccine in different colorectal cancer models #AACR24]
DOWNLOAD PR [๐ข๐๐ป๐๐ฒ๐ฟ๐ป๐ฎ๐๐ถ๐ผ๐ป๐ฎ๐น #๐๐๐๐ฅ๐ฎ๐ฌ๐ฎ๐ฐ] Brenus Pharma ๐ฝ๐ฟ๐ฒ๐๐ฒ๐ป๐๐ฒ๐ฑ ๐๐ผ๐ฑ๐ฎ๐ ๐ฝ๐ฟ๐ผ๐บ๐ถ๐๐ถ๐ป๐ด ๐ฎ๐ป๐ฑ ๐ฟ๐ผ๐ฏ๐๐๐ ๐ฎ๐ป๐๐ถ-๐๐๐บ๐ผ๐ฟ ๐ฒ๐ณ๐ณ๐ถ๐ฐ๐ฎ๐ฐ๐ ๐ณ๐ผ๐ฟ ๐ฆ๐ง๐-๐ญ๐ฌ๐ญ๐ฌ, ๐ป๐ฒ๐ ๐ ๐ด๐ฒ๐ป๐ฒ๐ฟ๐ฎ๐๐ถ๐ผ๐ป ๐ถ๐บ๐บ๐๐ป๐ผ๐๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐, during the Association Cancer Research Annual meeting in San Diego. This is validating our innovative approach to fight #resistant hashtag#tumors and highlighting STC-1010’s potential in clinical trials for treating colorectal cancer ; second leading cause of […]
[๐ขBrenus awarded French Biotech of the year 2024 ๐๐]
DOWNLOAD PR Bringing the trophy home ๐๐ Awarded by France Biotech last night, we are proud to bring back the cup to Lyon this morning and thank our wonderful team and strong partners for their passion and determination to accelerate innovation in oncology. ๐France Biotech: YOU ROCK ! Congratulations for building and coordinating the French […]
[๐ข5Mโฌ to obtain safety and efficacy clinical data in colorectal cancer ๐]
DOWNLOAD PR ๐ Brenus Pharma winner of the call for proposals hashtag#FRANCE2030 : 5Mโฌ to obtain safety and efficacy clinical data in colorectal cancer ๐ Nous sommes fiers d’annoncer que Brenus Pharma a รฉtรฉ dรฉsignรฉe laurรฉate de l’appel ร projet “Innovations en biothรฉrapies et bioproduction” du programme France 2030. โก๏ธCe financement majeur de prรจs […]
[๐ขPSCC : Let’s collaborate at the heart of innovation in oncology ๐]
DOWNLOAD PRESS RELEASE ๐ Let’s collaborate at the heart of innovation in oncology. ๐ Thrilled to share that Brenus Pharma is now part of the Paris Saclay Cancer Cluster (PSCC) (PSCC), the first national #Oncocluster! ๐ We are proud to be part of the national and European oncology innovation ecosystem. By combining PSCC’s strengths and […]
[๐ขStimulated Tumor Cells (STC) vaccine induces response in colorectal cancer #SITC23]
DOWNLOAD PRย ๐ฌ#SITC23 Thrilled to share new results we presented at the Society for Immunotherapy of Cancer (SITC) Congress!ย ๐ Many thanks to all contributors, Cรฉline Gongora Corentin Richard Romain Boidot Tanguy Fortin Alban Bessede Yan WANG Italiano Antoine Based on these vaccine characterization and preclinical, in-ovo and ex-vivo efficiency data, STC-1010 treatment will soon be […]
[๐ขBrenus annouces its international scientific committee]
LYON, (FRANCE), June 7th, 2023, โ Following theย American Society of Clinical Oncologyโs,ย Annual Meeting, where Brenusโ innovative approach and promising preclinical results were featured in the abstract section โTreatment to Followโ, the company highlighted its international scientific committee. View PDF
[๐ข BRENUS Pharma unveils groundbreaking preclinical results for STC-10101 , a promising new drug candidate targeting Colorectal Cancer & Solid Tumors. #AACR23]
DOWNLOAD PRย
[๐ข French Blood Establishment (EFS) & Brenus Pharma partner for the GMP production of STC-1010, an innovative therapy against colorectal cancer]
French Blood Establishment (EFS) & Brenus Pharma partner for the GMP production of STC-1010, an innovative therapy against colorectal cancer – DOWNLOAD PR
[๐ขPharma announces its Strategic Committee supporting & ensuring its value-creating strategic plan]
DOWNLOAD PRESS RELEASEย
[๐ขBrenus Pharma and InSphero receive โฌ1.5 million in grants from the European EUROSTARS fund for the development of a companion test for the next-generation cancer cell immunotherapy STC-1010]
DOWNLOAD PR Brenus Pharma and InSphero receive โฌ1.5 million in grants from the European EUROSTARS fund for the development of a companion test for the next-generation cancer cell immunotherapy STC-1010.